SB Investment Advisers (uk) Ltd., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 597,298 shares at $5.99 ($3.6M) on 2025-10-23, disclosed to the SEC on 2025-10-24.
Scheduled sale ($3.6M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.15 | 144,266 | $887K | 24.5% |
| 2 | $6.15 | 144,266 | $887K | 24.5% |
| 3 | $5.99 | 154,383 | $925K | 25.5% |
| 4 | $5.99 | 154,383 | $925K | 25.5% |
| Total | $6.07 avg | 597,298 | $3.6M | 100% |
| Filing → |
| VIR | SELL | 2025-10-09 | $6.4M | — | Filing → |
| CPNG | SELL | 2025-06-17 | $282.5M | — | Filing → |
| CPNG | SELL | 2025-05-12 | $772.5M | — | Filing → |